19 Comments
 

They’ve historically dominated biopharma and some of the partners own the relationships with Pfizer and Sanofi.

However, these restructuring mandates are pretty surprising in my view.

 
Funniest

Bro if you want to wear your cute little spooky ghost costume and pointed hat just do it, don’t be shy!

 

Point still stands though - CVP's seniors have very close relationships with Pfizer and Sanofi as well and have advised on numerous transactions involving Pfizer both for Pfizer and on the other side of the table (ex advised Pfizer on its acquisition of Arena Pharma). A strong relationship to Pfizer also makes them more likely to win a transaction on the other side of the table since the seniors have amicable relationships with Pfizer officials which helps with negotiations/familiarity.

 

Just happens to be right place and good timing. CVP has always been strong in biotech, Stuart Smith is one of the strongest large-cap HC services bankers around, and the firm has longstanding relationships with both Emerson Electric (courtesy of Gayle Turk) and Credit Suisse (courtesy of both Tadhg Flood and Effron himself). Just so happens that over the past couple of months large-cap biotech dealflow has popped off compared to a relatively quiet 2022, the Oak Street/CVS deal gets announced (which Smith was always going to be on given his credentials), Emerson Electric undergoes two large M&A deals in late 2022/early 2023, and CS decides to explode.

 

Odio minus ratione illo qui animi qui. Iusto amet impedit culpa voluptate. Dolore mollitia laboriosam magni repudiandae.

Optio ad ullam neque et error possimus quia. Ad est maiores autem sed nulla. Blanditiis facilis maiores sunt inventore distinctio ea iure.

Ab tempora molestias ut fugiat qui sed corrupti. Aut velit et aliquam dolore omnis suscipit hic. Exercitationem omnis laudantium qui omnis et. Inventore cum aperiam accusantium rerum.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 01 98.3%
  • BMO Capital Markets 13 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”